Giant Cell Arteritis Archives

Incidence of VTE, Stroke in GCA and Non-GCA Comparators

By

Alicia Ciccone

August 30, 2016

Retrospectively acquired population-based data suggest that the incidence of VTE, stroke and TIA was similar in patients with GCA compared to those who did not have GCA.

Spondyloarthritis

Lead Investigator Discusses Implications of the GiACTA Trial for GCA Treatment

By

Tori Rodriguez, MA, LPC

July 12, 2016

Rheumatology Advisor speaks with John Stone, MD, MPH, Edward Fox Chair in Medicine at Massachusetts General Hospital who is the lead investigator of a phase III, double-blind, randomized trial evaluating the safety and efficacy of tocilizumab for giant cell arteritis

General Rheumatology

Distinct Histological Patterns of GCA Described

By

Tori Rodriguez, MA, LPC

April 4, 2016

Researchers in this study sought to describe distinct histological subtypes of temporal artery biopsies.

Vasculitis

Can Tocilizumab Be Steroid-Sparing While Maintaining Remission in GCA?

By

Corinna Sison, MD

March 10, 2016

This is the first randomized placebo-controlled trial to demonstrate the induction and remission efficacy of IL-6 inhibition with tocilizumab in patients with giant cell arteritis (GCA).